Jan Kolcava

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Case report: Diagnostic challenge: a new multiple sclerosis "relapse" leading to the diagnosis of anaplastic astrocytoma.

Case report: Diagnostic challenge: a new multiple sclerosis "relapse" leading to the diagnosis of anaplastic astrocytoma.

Journal: Frontiers in neurology

Published: October 19, 2023

Screening for dysphagia in patients with relapsing-remitting multiple sclerosis.

Screening for dysphagia in patients with relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: August 23, 2023

Predictive factors of multiple sclerosis relapse after the first demyelinating event: A 5-year follow-up.

Predictive factors of multiple sclerosis relapse after the first demyelinating event: A 5-year follow-up.

Journal: Multiple sclerosis and related disorders

Published: December 25, 2022

Intensive Circuit Class Therapy in Patients with Relapsing-Remitting Multiple Sclerosis.

Intensive Circuit Class Therapy in Patients with Relapsing-Remitting Multiple Sclerosis.

Journal: Journal of rehabilitation medicine

Published: February 17, 2022

Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report.

Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report.

Journal: BMC neurology

Published: October 22, 2021

Progressive Tumefactive Demyelination as the Only Result of Extensive Diagnostic Work-Up: A Case Report.

Progressive Tumefactive Demyelination as the Only Result of Extensive Diagnostic Work-Up: A Case Report.

Journal: Frontiers in neurology

Published: April 28, 2021

The impact of lymphocytosis and CD4/CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumab.

The impact of lymphocytosis and CD4/CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumab.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: August 18, 2020

Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report.

Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report.

Journal: Multiple sclerosis and related disorders

Published: May 18, 2020

Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.

Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.

Journal: Multiple sclerosis and related disorders

Published: April 29, 2020

Sensory and pain modulation profiles of ongoing central neuropathic extremity pain in multiple sclerosis.

Sensory and pain modulation profiles of ongoing central neuropathic extremity pain in multiple sclerosis.

Journal: European journal of pain (London, England)

Published: March 29, 2020

The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings.

The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings.

Journal: Multiple sclerosis and related disorders

Published: October 24, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026